Specimen Gate Screening Center, Part Number 5002-0500, All software versions from 1.0 to 1.8 (cur...
FDA Device Recall #Z-1541-2018 — Class II — November 17, 2017
Recall Summary
| Recall Number | Z-1541-2018 |
| Classification | Class II — Moderate risk |
| Date Initiated | November 17, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | PerkinElmer Life and Analytical Sciences, Wallac, OY |
| Location | Turku, N/A |
| Product Type | Devices |
| Quantity | 8 |
Product Description
Specimen Gate Screening Center, Part Number 5002-0500, All software versions from 1.0 to 1.8 (current software version) Specimen Gate Screening Center is used for data management of neonatal screening test results and demographics by qualified laboratory personnel in newborn screening programs.
Reason for Recall
Potential errors in patient results generated by the Screening Center product that include both false negative and false positive results.
Distribution Pattern
Worldwide Distribution - US Distribution to the state of Georgia., and to the countries of : Belgium, Canada, Denmark, Italy, and United Kingdom.
Lot / Code Information
All software versions from 1.0 to 1.8 (current software version)
Other Recalls from PerkinElmer Life and Analytical Scien...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1239-2019 | Class II | AutoDELFIA¿ hCG Kit, In Vitro Diagnostic for th... | Jan 10, 2019 |
| Z-1237-2019 | Class II | DELFIA¿ hCG Kit, In Vitro Diagnostic for the de... | Jan 10, 2019 |
| Z-1238-2019 | Class II | AutoDELFIA¿ hCG Kit, In Vitro Diagnostic for th... | Jan 10, 2019 |
| Z-1692-2018 | Class II | NeoBase Succinylacetone Assay Solution, Product... | Nov 2, 2017 |
| Z-1220-2018 | Class III | AutoDELFIA Neonatal immunoreactive trypsin(ogen... | Sep 25, 2017 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.